Harry Sokol
0000-0002-2914-1822
Publication & Citation Trends
Publications
0 total
Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database
Cited by 4
Semantic Scholar
Author Correction: A genomic mutational constraint map using variation in 76,156 human genomes OA
Cited by 23
Semantic Scholar
Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries OA
Cited by 159
Semantic Scholar
Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease OA
Cited by 14
Semantic Scholar
CARD9, VAV3, and infection risk in IgA nephropathy.
Cited by 3
Semantic Scholar
DOP69 Glycans as an actor in the microbiome-immune response crosstalk OA
Cited by 0
Semantic Scholar
Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies OA
Cited by 262
Semantic Scholar
Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease OA
Cited by 0
Semantic Scholar
A high-throughput sequencing approach identifies immunotherapeutic targets for bacterial meningitis in neonates OA
Cited by 20
Semantic Scholar
Reduction in SARS-CoV-2 Virus Infectivity in Human and Hamster Feces OA
Cited by 7
Semantic Scholar
Research Topics
Gut microbiota and health
(258)
Inflammatory Bowel Disease
(166)
Clostridium difficile and Clostridium perfringens research
(137)
Microscopic Colitis
(122)
Gastrointestinal motility and disorders
(56)
Affiliations
Semmelweis University
Broad Institute
Dartmouth College
Délégation Paris 5
Novartis (Switzerland)